Astera Labs (NASDAQ:ALAB) Shares Up 11.1% – Time to Buy?

Astera Labs, Inc. (NASDAQ:ALAB) traded up 11.1% during trading on Thursday . The stock traded as high as $367.88 and last traded at $367.47. 5,666,583 shares traded hands during mid-day trading, an increase of 2% from the average session volume of 5,563,224 shares. The stock had previously closed at $330.86.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. UBS Group assumed coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target on the stock. Roth Mkm restated a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Susquehanna raised their price target on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Trading Up 11.1%

The firm has a 50-day moving average of $226.80 and a 200 day moving average of $176.02. The stock has a market capitalization of $62.99 billion, a price-to-earnings ratio of 248.29, a price-to-earnings-growth ratio of 4.52 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling

In related news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the sale, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,321,256 shares of company stock valued at $480,893,146. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the company. Assetmark Inc. grew its position in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares in the last quarter. Reflection Asset Management acquired a new position in Astera Labs during the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC increased its position in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the period. Hilltop National Bank increased its position in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the period. Finally, Aventura Private Wealth LLC acquired a new stake in Astera Labs in the 4th quarter valued at approximately $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.